3',4',7-trimethoxyflavone has been researched along with acacetin in 1 studies
| Studies (3',4',7-trimethoxyflavone) | Trials (3',4',7-trimethoxyflavone) | Recent Studies (post-2010) (3',4',7-trimethoxyflavone) | Studies (acacetin) | Trials (acacetin) | Recent Studies (post-2010) (acacetin) |
|---|---|---|---|---|---|
| 7 | 0 | 4 | 231 | 1 | 159 |
| Protein | Taxonomy | 3',4',7-trimethoxyflavone (IC50) | acacetin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.083 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.1655 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.167 | |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | 3.3 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.049 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.6967 | |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | 5.78 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 5.78 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.011 | |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 5.7 | |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | 9.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, H; Katayama, K; Masuyama, K; Mitsuhashi, J; Sugimoto, Y; Yoshioka, S | 1 |
1 other study(ies) available for 3',4',7-trimethoxyflavone and acacetin
| Article | Year |
|---|---|
Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
Topics: Antineoplastic Agents, Hormonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flavones; Flavonoids; Humans; Inhibitory Concentration 50; K562 Cells; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Structure-Activity Relationship; Topotecan | 2007 |